HomeTYRA • NASDAQ
add
Tyra Biosciences Inc
Previous close
$12.47
Day range
$12.25 - $12.56
Year range
$6.42 - $29.60
Market cap
667.28M USD
Avg Volume
219.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 31.45M | 33.66% |
Net income | -28.10M | -50.24% |
Net profit margin | — | — |
Earnings per share | -0.47 | -46.87% |
EBITDA | -31.31M | -33.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 296.27M | -20.74% |
Total assets | 321.50M | -18.08% |
Total liabilities | 19.35M | 17.87% |
Total equity | 302.15M | — |
Shares outstanding | 53.30M | — |
Price to book | 2.20 | — |
Return on assets | -23.65% | — |
Return on capital | -24.66% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -28.10M | -50.24% |
Cash from operations | -23.68M | -130.84% |
Cash from investing | 20.87M | 114.39% |
Cash from financing | 583.00K | 56.30% |
Net change in cash | -2.23M | 98.56% |
Free cash flow | -13.92M | -155.45% |
About
Founded
2018
Headquarters
Website
Employees
60